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Purpose: To retrospectively determine whether baseline nodule
characteristics at 3-month and 1-year volume doubling
time (VDT) are predictive for lung cancer in solid indeter-
minate noncalcified nodules (NCNs) detected at baseline
computed tomographic (CT) screening.
Materials and
Methods:
The study, conducted between April 2004 and May 2006,
was institutional review board approved. Patient consent
was waived for this retrospective evaluation. NCNs be-
tween 5 and 10 mm in diameter (n  891) were evaluated
at 3 months and 1 year to assess growth (VDT  400
days). Baseline assessments were related to growth at 3
months and 1 year by using 2 and Mann-Whitney U tests.
Baseline assessments and growth were related to the pres-
ence of malignancy by using univariate and multivariate
logistic regression analyses.
Results: At 3 months and at 1 year, 8% and 1% of NCNs had
grown, of which 15% and 50% were malignant, respec-
tively. One-year growth was related to morphology (P 
.01), margin (P  .0001), location (P  .001), and size
(P  .01). All cancers were nonspherical and purely intra-
parenchymal, without attachment to vessels, the pleura,
or fissures. In nonsmooth unattached nodules, a volume of
130 mm3 or larger was the only predictor for malignancy
(odds ratio, 6.3; 95% confidence interval [CI]: 1.7, 23.0).
After the addition of information on the 3-month VDT,
large volume (odds ratio, 4.9; 95% CI: 1.2, 20.1) and
3-month VDT (odds ratio, 15.6; 95% CI: 4.5, 53.5) helped
predict malignancy. At 1 year, only the 1-year growth
remained (odds ratio, 213.3; 95% CI: 18.7, 2430.9) as
predictor for malignancy.
Conclusion: In smooth or attached solid indeterminate NCNs, no ma-
lignancies were found at 1-year follow-up. In nonsmooth
purely intraparenchymal NCNs, size is the main baseline
predictor for malignancy. When follow-up data are avail-
able, growth is a strong predictor for malignancy, espe-
cially at 1-year follow-up.
 RSNA, 2008
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W ith the advent of low-dose mul-tidetector computed tomo-graphic (CT) technology and
the use of smaller collimations, the de-
tection of small subcentimeter noncalci-
fied nodules (NCNs) of the lung has in-
creased substantially, with prevalence
rates between 61% and 92% in different
screening programs (1,2). Several in-
vestigators (3) have reported that the
likelihood of malignancy in NCNs
smaller than 5 mm is almost negligible.
The category of indeterminate NCNs
between 5 and 10 mm is more challeng-
ing. They are less amenable than larger
nodules for characterization by means
of positron emission tomography (PET)
or percutaneous biopsy (4), and the ac-
curacy of CT-guided biopsy is substan-
tially lower (5). Therefore, the Fleis-
chner Society (6) recommended two to
three follow-up CT scans for incidental
nodules between 6 and 8 mm. Only if no
growth is observed after 24 months, a
nodule can, according to these recom-
mendations, be regarded as benign.
Once growth has been observed, the
likelihood of malignancy increases, but
benign lesions may also grow (5). Inten-
sive observation policies are a financial
burden for patients and society, and ad-
ditional invasive diagnostic procedures,
such as CT-guided biopsy, after the as-
sessment of growth may incur patient
morbidity. Another limitation of the
growth criterion is that two-dimen-
sional measurements are unreliable in
the evaluation of small indeterminate
nodules and that three-dimensional
software is required for reliable esti-
mates (7).
If it were possible to identify NCNs,
which are not very likely to be malig-
nant, follow-up CT of these lesions
could be avoided, which would reduce
radiation exposure, anxiety, and costs.
Thus, the purpose of our study was to
retrospectively determine whether
baseline nodule characteristics at
3-month and 1-year volume doubling
time (VDT) are predictive for lung can-
cer in solid indeterminate NCNs de-
tected at baseline CT screening.
Materials and Methods
Participants
The Dutch-Belgian randomized lung
cancer screening trial (known as the
NELSON study) (8) was institutional re-
view board approved. Our study was
part of the NELSON study. For our
study, participants with one to five solid
indeterminate NCNs between 50 and
500 mm3, corresponding to a diameter
of 4.6–9.8 mm at baseline screening,
were selected between April 2004 and
May 2006 (9). According to the NELSON
protocol, all participants with at least one
indeterminate NCN were invited to un-
dergo 3-month repeat scanning to deter-
mine whether the nodule had grown (9).
The NELSON study was approved by the
medical ethics committees of all institu-
tions, and all subjects gave their written
informed consent. Informed patient
consent was waived for this retrospec-
tive evaluation.
Data Acquisition
At all four screening sites, 16-section
multidetector CT scanners (Mx8000
IDT or Brilliance 16P, Philips Medical
Systems, Cleveland, Ohio; Sensation
16, Siemens Medical Solutions, Forch-
heim, Germany) were used. Scanning of
the entire chest was performed in a cau-
docranial direction. Scanning data were
obtained in the spiral mode, with 16
detector rows, 0.75-mm section thick-
ness, and a pitch of 1.5. No contrast
material was used. Low-dose settings
were applied. Depending on body
weight (50, 50–80, or 80 kg), the
peak voltage settings were 80–90, 120,
and 140 kVp, respectively, to achieve
volume CT dose index values of approx-
imately 0.8, 1.6, and 3.2 mGy, respec-
tively. The tube current–time product
settings were adjusted accordingly, de-
pending on the machine used. To mini-
mize breathing artifacts, scans were
performed at suspended maximal inspi-
ration after appropriate instruction to
the subjects. Data were reconstructed
at 1.0-mm section thickness, with a
0.7-mm reconstruction increment.
Image Analysis
All CT images were read at two inde-
pendent readings. First readings were
performed by radiologists with back-
grounds varying from 1 to 20 years of
experience in reading thoracic CT im-
ages. Second readings were performed
by two radiologists (D.M.X. and Y.W.,
both with 6 years of experience). In the
case of a discrepancy between the two
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Advances in Knowledge
 In smooth solid indeterminate
pulmonary nodules or nodules
attached to a fissure, the pleura,
or located juxtavascularly (volume
between 50 and 500 mm3), can-
cer risk is absent at 1 year of fol-
low-up.
 In nonsmooth purely intraparen-
chymal solid indeterminate pul-
monary nodules, volume is the
only predictor for malignancy at
baseline screening.
 A volume doubling time of less
than 400 days at 1-year follow-up
has a positive predictive value of
63% for malignancy in solid inde-
terminate pulmonary nodules.
Implication for Patient Care
 Smooth or attached (to a fissure,
the pleura, or a vessel) solid inde-
terminate pulmonary nodules re-
quire no shorter follow-up than 1
year.
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independent readers, a radiologist
(M.O., with 15 years of experience in
lung CT) made the final decision. A soft-
ware package (Syngo Lungcare, version
Somaris/5 VB 10A; Siemens Medical
Solutions, Erlangen, Germany) de-
signed to aid the radiologist in the de-
tection of pulmonary nodules was used
with a workstation (Leonardo; Siemens
Medical Solutions, Erlangen, Ger-
many), in addition to visual readings.
Volumes were calculated by using three-
dimensional volumetric computer soft-
ware (Lungcare). In cases of inappro-
priate segmentation, the radiologist was
able to enter manual measurements as
well, which then overruled the automat-
ically generated volume calculations as
described earlier (9). Baseline and fol-
low-up images were reviewed and dis-
played simultaneously on one worksta-
tion. All images were interpreted at lung
window (window width, 1600 HU; win-
dow level, 700 HU) and mediastinal
settings (window width, 400 HU; win-
dow level, 50 HU).
Nodule Features
An NCN was defined as solid if its lung
opacity completely obscured the under-
lying structures (10). On the basis of
morphology, NCNs were classified as ei-
ther spherical or nonspherical. A nod-
ule was considered spherical if the max-
imal diameter was less than twice the
minimal diameter; otherwise, it was
considered nonspherical. The location
of the nodule refers to its intrapulmo-
nary position. An NCN was considered
attached if the length of the contact sur-
face with other pulmonary structures
(fissure, the pleura, or vessel) was more
than 50% of the diameter of the nodule
at volume-rendered reconstruction or
on transverse images; otherwise, it was
considered purely intraparenchymal.
Subsequently, attached nodules were
further classified according to the pul-
monary structures to which they were
attached: Fissure-attached nodules were
attached to a minor or major fissure
(Fig 1); pleural-based nodules had pleu-
ral contact (Fig 2); and juxtavascular
nodules were attached to a vessel, but
were not considered juxtavascular if
they were attached to the tip of a vessel
(Fig 3). Because the 50% contact crite-
rion was difficult to apply to nonspheri-
cal nodules due to their irregular shape,
these nodules were classified as at-
tached only if the major part of their
surface was in contact with these struc-
tures; otherwise, they were considered
purely intraparenchymal.
NCNs were also classified according
to their margin as smooth, lobulated, or
Figure 1
Figure 1: (a) Transverse thin-section CT and (b) volume-rendered reconstruction images show spherical
solid fissure-attached pulmonary nodule (arrow in a and yellow area in b) detected at baseline screening in the
NELSON study.
Figure 2
Figure 2: (a) Transverse thin-section CT and (b) volume-rendered reconstruction images show solid pleu-
ral-based pulmonary nodule (arrow in a and green area in b) detected at baseline screening in the NELSON
study.
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spiculated or irregular (11). Lobulation
was defined as an abrupt bulging of the
contour of the lesion (12), and spicula-
tion was defined as the presence of
thicker strands extending from the nod-
ule margin into the lung parenchyma
without reaching the pleural surface
(13). According to the NELSON proto-
col, participants with indeterminate
nodules underwent repeat scanning at 3
months to assess growth. Growth was
defined as a volume increase of at least
25% after at least a 3-month interval,
which corresponded with a VDT of less
than 400 days (9). If there was no malig-
nancy detected at 3-month follow-up, a
1-year follow-up CT examination was
performed. If the indeterminate nodules
were stable at the second-round CT
study 1 year later, participants under-
went a third-round CT study 2 years
later. The total duration of the follow-up
period of all participants was 6 years.
Study End Points
A participant with one or more indeter-
minate NCNs with a VDT of less than
400 days at 3 months or 1 year was
referred to a pulmonologist for work-up
and final pathologic diagnosis (9). An
NCN was classified as malignant only on
the basis of histologic examination find-
ings of tissue specimens. An NCN was
classified as benign when either: (a) the
nodule was benign at histologic exami-
nation; (b) extensive work-up by a pul-
monologist, including contrast mate-
rial–enhanced CT, PET, and bronchial
washing, had a negative finding; (c) the
VDT was more than 600 days at 1-year
follow-up; or (d) the nodule had de-
creased in volume or completely re-
solved at 1-year follow-up.
Statistical Analysis
The baseline variables morphology (spher-
ical or nonspherical) and margin
(smooth, lobulated, or spiculated) were
related to location and size; these rela-
tions were tested by using 2 and Mann-
Whitney U tests, respectively. Subse-
quently, morphology, margin, location,
and size were related to the VDT at 3
months. In this analysis, VDT was dichot-
omized into less than 400 days versus 400
days or longer. A nongrowing tumor had
by definition a VDT of 400 days or longer
at 3 months. The relations were tested by
applying 2 and Mann-Whitney U tests.
Finally, the baseline variables morphol-
ogy, margin, location, and baseline vol-
ume were related to the VDT at 1 year. In
this analysis, VDT was categorized into
less than 400 days, 400–600 days, or 600
days or longer. A nongrowing tumor at 1
year had by definition a VDT of 600 days
or longer. The relations were tested by
applying 2 and Mann-Whitney U tests.
Figure 3
Figure 3: (a) Transverse thin-section CT and (b) volume-rendered reconstruction images show solid jux-
tavascular pulmonary nodule (arrow in a and yellow area in b) detected at baseline screening in the NELSON
study.
Table 1
Distribution of Morphology and Margin in 891 Solid Indeterminate Nodules Detected
at Baseline Screening in the NELSON Trial
Variable
Location
Median Baseline
Volume (mm3)*Total Intraparenchymal Juxtavascular
Fissure
Attached Pleural Based
Morphology
Spherical 767 (100) 303 (39) 130 (17) 189 (25) 145 (19) 84 (50–492)
Nonspherical 124 (100) 109 (88) 1 (1) 2 (1) 12 (10)† 121 (52–499)‡
Total 891 (100) 412 (46) 131 (15) 191 (21) 157 (18) 86 (50–499)
Margin
Smooth 654 (100) 264 (40) 102 (16) 149 (23) 139 (21) 81 (50–492)
Lobulated 168 (100) 90 (54) 24 (14) 41 (24) 13 (8) 88 (51–465)
Spiculated 69 (100) 58 (84) 5 (7) 1 (1) 5 (7)§ 222 (61–499)
Note.—Unless otherwise indicated, data are numbers of nodules, with percentages in parentheses.
* Data in parentheses are ranges.
† 2 value of 104.6; degrees of freedom, three; P  .0001.
‡ Mann-Whitney U test; spherical versus nonspherical; P  .0001.
§ 2 value of 63.7; degrees of freedom, six; P  .0001.
 Mann-Whitney U test; spiculated versus lobulated or smooth; P  .0001.
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The relations between morphology,
margin, location, baseline volume, and
VDT at 3 months and 1 year and the
presence of malignancy during 1 year of
follow-up were studied by using univari-
ate logistic regression analyses, for
which malignancy was the dependent
variable. Odds ratios and 95% confi-
dence intervals (CIs) were calculated
for each independent variable with re-
gard to the presence of malignancy. In
this analysis, VDT at 1 year was valued
as less than 400 days if the VDT at 3
months or at 1 year of follow-up was
less than 400 days. Otherwise, the VDT
at 1 year was valued as 400 days or
longer. Baseline volume was dichoto-
mized into small (50–130 mm3) versus
large (130–500 mm3). The cutoff of 130
mm3 was based on the third quartile (ie,
75% of the nodules were smaller and
25% were larger).
Because smooth or attached nod-
ules were never related to the presence
of malignancy, these nodules were ex-
cluded from multivariate logistic regres-
sion analyses. The first multivariate lo-
gistic regression model was based on
the variables morphology, margin (lob-
ulated or spiculated), and baseline vol-
ume, with malignancy as the dependent
variable. In the second model, the VDT
at 3 months was added to the significant
baseline variables, and in the third
model, the VDT at 1 year was added to
the significant baseline variables. P val-
ues less than .05 were considered to
indicate statistically significant differ-
ences. All analyses were performed
with software (SPSS, version 14.01;
SPSS, Chicago, Ill).
Results
Participants
Of the 6868 participants who under-
went baseline screening between April
2004 and May 2006, 658 participants
with a total of 891 solid indeterminate
NCNs met the inclusion criteria for this
study. The median age of the partici-
pants was 62 years (range, 52–78
years). Of them, 631 (95.9%) were men
and 27 (4.1%) were women. In 2% (16
of 891) of the indeterminate nodules,
Table 2
Distribution of VDTs at 3-month Follow-up in 875 Solid Indeterminate Nodules
according to Variables
Variable
VDT
Total VDT 400 Days 400 Days
Morphology
Spherical 754 52 (7) 702 (93)
Nonspherical 121 16 (13) 105 (87)*
Margin
Smooth 643 43 (7) 600 (93)
Lobulated 164 13 (8) 151 (92)
Spiculated 68 12 (18) 56 (82)†
Location
Intraparenchymal 407 40 (10) 367 (90)
Attached 468 28 (6) 440 (94)‡
Juxtavascular 123 10 (8) 113 (92)
Fissure attached 190 10 (5) 180 (95)
Pleural based 155 8 (5) 147 (95)
Median baseline volume (mm3)§ 875 83 (50–465) 86 (50–499)
Note.—Unless otherwise indicated, data are numbers of nodules, with percentages in parentheses. For 16 indeterminate
nodules, 3-month repeat scanning was not performed.
* 2 value of 5.8; degrees of freedom, one; P  .05.
† 2 value of 10.3; degrees of freedom, two; P  .01.
‡ 2 value of 4.5; degrees of freedom, one; P  .05.
§ Data in parentheses are ranges.
 Mann-Whitney U test; difference between VDT groups: P  .03.
Table 3
Distribution of VDTs at 1-year Follow-up in 878 Solid Indeterminate Nodules
according to Variables
Variable
VDT
Total VDT 400 Days 400–600 Days 600 Days
Morphology
Spherical 759 5 (1) 18 (2) 736 (97)
Nonspherical 119 5 (4) 4 (3) 110 (93)*
Margin
Smooth 652 2 (0) 14 (2) 636 (98)
Lobulated 162 2 (1) 5 (3) 155 (96)
Spiculated 64 6 (9) 3 (5) 55 (86)†
Location
Intraparenchymal 400 10 (3) 11 (3) 379 (94)
Attached 478 0 11 (2) 467 (98)‡
Juxtavascular 131 0 3 (2) 128 (98)
Fissure attached 191 0 5 (3) 186 (97)
Pleural based 156 0 3 (2) 153 (98)
Median baseline volume (mm3)§ 878 235 (82–498) 86 (58–470) 85 (50–499)
Note.—Unless otherwise indicated, data are numbers of nodules, with percentages in parentheses. For 13 indeterminate
nodules, no 1-year CT study was performed.
* 2 value of 12.0; degrees of freedom, two; P  .01.
† 2 value of 44.7; degrees of freedom, four; P  .0001.
‡ 2 value of 12.3; degrees of freedom, two; P  .01.
§ Data in parentheses are ranges.
 Mann-Whitney U test; difference between VDT of less than 400 days versus 400 days or longer; P  .01.
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the 3-month repeat study was not per-
formed: One subject (one nodule) was
referred to the pulmonologist after
baseline screening and underwent sec-
ond-round screening 1 year later; in
eight subjects (eight nodules), the nod-
ules were missed at baseline screening
but were retrospectively evaluated at
second-round screening; five subjects
(seven nodules) did not show up for the
3-month repeat examination. In 2% (13
of 891) of the indeterminate nodules, no
1-year CT scanning was performed: Ten
subjects (10 nodules) went to routine
clinical care after the detection of lung
cancer at 3 months; two subjects (two
nodules) went to routine clinical care
after surgical resection of a growing
nodule at 3 months; one subject (one
nodule) did not show up at 1-year fol-
low-up.
Nodule Features at Baseline Screening
Eighty-six percent (767 of 891) of the
nodules were spherical, and 14% (124
of 891) were nonspherical; 73% (654 of
891) were smooth, 19% (168 of 891)
were lobulated, and 8% (69 of 891)
were spiculated or irregular (Table 1).
Forty-six percent (412 of 891) were
purely intraparenchymal, and 54% (479
of 891) were attached. Smooth or at-
tached indeterminate NCNs comprised
83% (743 of 891) of all indeterminate
solid pulmonary nodules detected. Non-
spherical nodules were more frequently
purely intraparenchymal (with regard
to location) than expected, whereas
spherical nodules were more often jux-
tavascular, fissure attached, or pleural
based (P  .0001). Spiculated or irreg-
ular nodules were more frequently in-
traparenchymal than expected (P 
.0001) (Table 1).
The median baseline volume of non-
spherical nodules was 121 mm3 (range,
52–499 mm3; corresponding diameter,
6.1 mm) versus 84 mm3 (range, 50–492
mm3; corresponding diameter, 5.4 mm)
in spherical nodules (P  .0001). The
median baseline volume was 222 mm3
(range, 61–499 mm3; corresponding di-
ameter, 7.5 mm) in spiculated or irreg-
ular nodules versus 81 mm3 (range, 50–
492 mm3; corresponding diameter, 5.3
mm) in smooth and 88 mm3 (range,
51–465 mm3; corresponding diameter,
5.5 mm) in lobulated nodules (P 
.0001) (Table 1).
Three-month and 1-year Follow-up
VDT at 3 months was assessed in 98%
(875 of 891) of the nodules, and 8% (68
of 875) had a VDT of less than 400 days.
The VDT at 3-month follow-up was de-
pendent on baseline morphology (P 
.05), margin (P  .01), and location
(P  .05) but was independent of base-
line volume (Table 2). The VDT at
1-year follow-up was assessed in 99%
(878 of 891) of the nodules, and 1% (10
of 878) had a VDT of less than 400 days.
The VDT at 1-year follow-up was re-
lated to baseline morphology (P  .01),
margin (P  .0001), location (P 
.001), and baseline volume (P  .01)
(Table 3).
Cancer Cases Detected
Sixteen (1.8%) of the 891 solid indeter-
minate nodules were malignant, and
875 were benign. After work-up and di-
agnosis of the 68 growing nodules at
3-month follow-up, 10 (15%) of them
were malignant (four squamous cell car-
cinomas, four adenocarcinomas, one
large cell carcinoma, and one neuroen-
docrine carcinoma). Six of them were
spherical, and four were nonspherical;
five had a spiculated margin, and five
were lobulated. The other 58 nodules
with a VDT of less than 400 days were
classified as benign after extensive
work-up by a pulmonologist, including
contrast-enhanced CT, PET, and bron-
choscopy with bronchial washing for cy-
tology. All these participants returned
into the screening program and under-
went second-round CT scanning at 1
year (Table 2).
After work-up and diagnosis of the
10 nodules with a VDT of less than 400
days at 1-year follow-up, five (50%) of
10 were malignant (one squamous cell
carcinoma, three adenocarcinomas,
and one large cell carcinoma). One of
them was spherical, and four were non-
spherical; all five malignant nodules had
Table 4
Results of Univariate Logistic Regression Analyses between Variables and Presence
of Lung Cancer during 1-year Follow-up in 891 Nodules
Variable Lung Cancer* Odds Ratio†
Morphology
Spherical 0.9 (7/767) 1
Nonspherical 7.3 (9/124) 8.5 (3.1, 23.3)
Margin
Smooth 0 (0/654) NA
Lobulated 3.6 (6/168) 1
Spiculated 14.5 (10/69) 4.7 (1.6, 13.5)
Location
Intraparenchymal 3.9 (16/412)
Attached 0 (0/503) NA
Baseline volume (mm3)
130 0.4 (3/668) 1
130 5.8 (13/223) 13.7 (3.9, 48.6)
VDT at 3 months (d)‡
400 0.7 (6/807) 1
400 14.7 (10/68) 23.0 (8.1, 65.5)
VDT at 1 year (d)§
400 0.1 (1/868) 1
400 50.0 (5/10) 867.0 (85.2, 8822.4)
* Data are percentages, with numbers used to calculate percentages in parentheses.
† Data in parentheses are 95% CIs. NA  not applicable.
‡ For 16 indeterminate nodules, 3-month repeat scanning was not performed.
§ For 13 indeterminate nodules, 1-year CT scanning was not performed.
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spiculated margins. The other five nod-
ules with a VDT of less than 400 days
were considered benign after extensive
work-up by a pulmonologist, including
contrast-enhanced CT, PET, and bron-
choscopy with bronchial washing for cy-
tology. One cancer had a VDT between
400 and 600 days (adenocarcinoma)
(Table 3).
Predictors for Malignancy
According to univariate logistic regres-
sion analyses, nonspherical morphol-
ogy, lobulated or spiculated margins,
purely intraparenchymal location, and a
larger baseline volume were all signifi-
cantly related to the presence of lung
cancer (Table 4). During follow-up, a
VDT of less than 400 days at 1 year was
significantly related to the presence of
lung cancer (positive predictive value of
63%). None of the smooth nodules were
malignant, whereas 14.5% (10 of 69) of
the spiculated or irregular nodules and
3.6% (six of 168) of the lobulated nod-
ules were malignant. All cancers were
purely intraparenchymal, and no cancer
cases originated from attached nodules.
When the group of attached or
smooth nodules—in which no cancers
originated—was excluded, a large base-
line volume (130 mm3) was the only
significant baseline predictor for malig-
nancy (odds ratio, 6.3; 95% CI: 1.7,
23.0). The addition of information on
the 3-month VDT yielded a second
model in which a large baseline volume
(130 mm3) was a significant predictor
of malignancy (odds ratio, 4.9; 95% CI:
1.2, 20.1), as well as the 3-month VDT
(odds ratio, 15.6; 95% CI: 4.5, 53.5). A
third model including baseline volume
and 1-year VDT showed that a large
baseline volume (130 mm3) was no
longer a significant predictor of malig-
nancy, but, in contrast, the 1-year VDT
(odds ratio, 213.3; 95% CI: 18.7,
2430.9) became a very strong predictor
(Table 5). In this series, the baseline
probability for having a malignant nod-
ule was 1.8%.
Discussion
During the past few years, a lot of new
information has become available on
the value of size, shape, and margin in
the discrimination of benign from malig-
nant CT-detected pulmonary nodules
(3,5,14–19). Nodules less than 3 mm in
diameter have only a 0.2% chance of
being malignant; this chance is 0.9% for
nodules between 4 and 7 mm, 18% for
nodules between 8 and 20 mm, and
50% for those larger than 20 mm (6). In
addition to size, the consistency of the
nodule (ie, solid, partially solid, non-
solid) and VDT are also predictive for
malignancy. Nonsolid nodules (pure
ground-glass opacities) tend to grow
slowly with VDTs of approximately 800
days and a 34% chance of being malig-
nant. Partially solid nodules have the
highest probability of malignancy
(40%–50%), with VDTs of around 450
days, while solid nodules (10 mm)
have VDTs around 150 days and a ma-
lignancy rate of 15% (5,20). The group
of baseline-detected indeterminate solid
pulmonary nodules between 50 and 500
mm3 in size, with diameters of 5–10
mm, gives rise to diagnostic problems
because of their small size. Therefore,
the Fleischner Society recommended
performing one or more follow-up stud-
ies to assess growth (6). Although we
confirmed in our study that a VDT of
less than 400 days at 1 year is a very
strong predictor for malignancy, with a
positive predictive value of 63% in inde-
terminate solid nodules, additional par-
ticipant (ie, presence of chronic ob-
structive pulmonary disease) and nod-
ule (ie, location in the upper lobes)
features are needed at baseline screen-
ing to improve diagnostic accuracy and
to avoid repeat CT examinations and
the inevitable associated diagnostic in-
terventions. Furthermore, diagnostic
accuracy of the growth criterion at 3
months appeared to be relatively low
because benign lesions may also grow
(5), as was illustrated in our study: Only
15% of the nodules with significant
growth at 3 months were malignant.
In our study, we identified, to our
knowledge, two new independent nega-
tive predictive factors for malignancy in
indeterminate solid NCNs detected in a
population at high risk for lung cancer
Table 5
Results of Multivariate Logistic Regression Analyses between Variables and Presence
of Lung Cancer during 1-year Follow-up in 148 Nodules
Variable Lung Cancer*
Odds Ratio†
Model 1 Model 2 Model 3
Morphology
Spherical 10.4 (7/67)
Nonspherical 11.1 (9/81) NS NS NS
Margin
Lobulated 6.7 (6/90)
Spiculated 17.2 (10/58) NS NS NS
Baseline volume (mm3)
130 3.7 (3/81) 1 1 1
130 19.4 (13/67) 6.3 (1.7, 23.0) 4.9 (1.2, 20.1) NS
VDT at 3 months (d)‡
400 4.8 (6/125) 1 1
400 47.6 (10/21) NI 15.6 (4.5, 53.5) NI
VDT at 1 year (d)§
400 0.8 (1/131) 1
400 62.5 (5/8) NI NI 213.3 (18.7, 2430.9)
Note.—Smooth or attached nodules were excluded.
* Data are percentages, with numbers used to calculate percentages in parentheses.
† Data in parentheses are 95% CIs. NI  not included in the model, NS  not significant, excluded from the model.
‡ Analysis was based on 146 nodules; two subjects (two nonattached nodules with nonsmooth margins) did not show up at
3-month follow-up.
§ Analysis was based on 139 nodules; 10 subjects went to routine clinical care after the detection of lung cancer at 3 months,
and one subject went to routine clinical care after surgical resection of a growing nodule at 3 months.
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who participated in a multisection CT
screening trial for lung cancer. In
smooth or attached nodules, no malig-
nancies were found, despite the fact
that some of them showed indetermi-
nate or even high growth rates during a
1-year follow-up period. In contrast, all
cancers originated from purely intrapa-
renchymal nodules. Smooth or attached
indeterminate NCNs comprised 83% of
all indeterminate solid pulmonary nod-
ules detected and are as such a common
finding. On the basis of these observa-
tions, we recommend that, in this type
of indeterminate nodule detected at
baseline screening, 1-year follow-up CT
scanning is sufficient, without additional
repeat scanning at 3 or 6 months. The
histologic correlates of pleural-based
opacities are most often scars, pleural
plaques, or small postinfarction fibrotic
lesions. The triangular or ovoid nodules
adjacent to the fissures may represent
intrapulmonary lymph nodes, which
may rapidly grow or decrease in size
(21,22). The juxtavascular nodules may
represent small lymph nodes or small
branching vessels, while bronchiolitis or
a small bronchiectasis may also appear
as a vessel- or fissure-attached nodule.
In nonsmooth purely intraparenchy-
mal NCNs, only baseline volume ap-
peared to be a predictor for malignancy,
while morphology and margin were not.
When follow-up information on growth
was available, a VDT of less than 400
days at 3 months was also a predictor
for malignancy. At 1-year follow-up, the
only very strong predictor for malig-
nancy was a VDT of less than 400 days.
The correlation between baseline nod-
ule volume and cancer risk found in our
study is consistent with the results of
other studies (3,23,24). When adjusted
for baseline size, a spiculated margin
appeared no longer predictive at multi-
variate analysis.
Although our study represents, to
our knowledge, one of the largest series
of low-dose multisection CT screening–
detected indeterminate solid NCNs, it
was limited by the relatively small num-
bers of lung cancer cases detected
among them and by the relatively short
follow-up period of only 1 year. It might
be possible that some of the NCNs de-
tected may be cancer cases after ex-
tended follow-up. This might be due to
the fact that cancer growth is not always
linear and may be sigmoid shaped, with
an acceleration phase after a period of
apparent absence of growth (25). This
was illustrated by the fact that in our
study six cancers detected at 1-year fol-
low-up had a VDT of more than 400
days at 3 months. However, Revel et al
(26) demonstrated that the negative
predictive value for cancer in solid nod-
ules with a VDT of more than 500 days
is very high (98%). Therefore, the con-
clusions of our study could apply for a
1-year follow-up period after baseline
screening. Another limitation of our
study was the fact that the VDT was a
criterion for referral, and the strength
of the positive predictive value of this
predictor may be caused by partial ver-
ification bias. There is, however, no
doubt that growth is a strong predictor
of malignancy in clinical practice, and
the exact quantification of this strength
is therefore of little relevance.
In conclusion, no malignancies were
found at 1-year follow-up in smooth or
attached solid indeterminate NCNs. In
nonsmooth purely intraparenchymal
NCNs, baseline size was the only predic-
tor for malignancy. When follow-up
data were available, growth was a
strong predictor for malignancy, espe-
cially at 1-year follow-up.
References
1. Gohagan J, Marcus P, Fagerstrom R, Pinsky
P, Kramer B, Prorok P. Baseline findings of a
randomized feasibility trial of lung cancer
screening with spiral CT scan vs chest
radiograph: the Lung Screening Study of the
National Cancer Institute. Chest 2004;126:
114–121.
2. Henschke CI, McCauley DI, Yankelevitz DF,
et al. Early Lung Cancer Action Project:
overall design and findings from baseline
screening. Lancet 1999;354:99–105.
3. Henschke CI, Yankelevitz DF, Naidich DP,
et al. CT screening for lung cancer: suspi-
ciousness of nodules according to size on
baseline scans. Radiology 2004;231:164–
168.
4. Benjamin MS, Drucker EA, McLoud TC,
Shepard JA. Small pulmonary nodules: de-
tection at chest CT and outcome. Radiology
2003;226:489–493.
5. Winer-Muram HT. The solitary pulmonary
nodule. Radiology 2006;239:34–49.
6. MacMahon H, Austin JH, Gamsu G, et al.
Guidelines for management of small pulmo-
nary nodules detected on CT scans: a state-
ment from the Fleischner Society. Radiology
2005;237:395–400.
7. Revel MP, Bissery A, Bienvenu M, Aycard L,
Lefort C, Frija G. Are two-dimensional CT
measurements of small noncalcified pulmo-
nary nodules reliable? Radiology 2004;231:
453–458.
8. van Iersel CA, de Koning HJ, Draisma G,
et al. Risk-based selection from the general
population in a screening trial: selection cri-
teria, recruitment and power for the Dutch-
Belgian randomised lung cancer multi-slice
CT screening trial (NELSON). Int J Cancer
2007;120:868–874.
9. Xu DM, Gietema H, de Koning H, et al.
Nodule management protocol of the NELSON
randomised lung cancer screening trial. Lung
Cancer 2006;54:177–184.
10. Suzuki K, Asamura H, Kusumoto M, Kondo
H, Tsuchiya R. “Early” peripheral lung
cancer: prognostic significance of ground
glass opacity on thin-section computed to-
mographic scan. Ann Thorac Surg 2002;74:
1635–1639.
11. Gurney JW. Determining the likelihood of
malignancy in solitary pulmonary nodules
with Bayesian analysis. I. Theory. Radiology
1993;186:405–413.
12. Takashima S, Maruyama Y, Hasegawa M,
et al. CT findings and progression of small
peripheral lung neoplasms having a replace-
ment growth pattern. AJR Am J Roentgenol
2003;180:817–826.
13. Takashima S, Sone S, Li F, et al. Small soli-
tary pulmonary nodules ( or 1 cm) de-
tected at population-based CT screening for
lung cancer: reliable high-resolution CT fea-
tures of benign lesions. AJR Am J Roentge-
nol 2003;180:955–964.
14. Murakami T, Yasuhara Y, Yoshioka S,
Uemura M, Mochizuki T, Ikezoe J. Pulmo-
nary lesions detected in population-based CT
screening for lung cancer: reliable findings of
benign lesions. Radiat Med 2004;22:287–
295.
15. Takashima S, Sone S, Li F, Maruyama Y,
Hasegawa M, Kadoya M. Indeterminate soli-
tary pulmonary nodules revealed at popula-
tion-based CT screening of the lung: using
first follow-up diagnostic CT to differentiate
benign and malignant lesions. AJR Am J
Roentgenol 2003;180:1255–1263.
16. Wang JC, Sone S, Feng L, et al. Rapidly
growing small peripheral lung cancers de-
THORACIC IMAGING:Predictive Nodule Characteristics at Follow-up Xu et al
Radiology: Volume 250: Number 1—January 2009 271
tected by screening CT: correlation between
radiological appearance and pathological
features. Br J Radiol 2000;73:930–937.
17. Jeong YJ, Lee KS, Jeong SY, et al. Solitary
pulmonary nodule: characterization with
combined wash-in and washout features at
dynamic multi-detector row CT. Radiology
2005;237:675–683.
18. Furuya K, Murayama S, Soeda H, et al. New
classification of small pulmonary nodules by
margin characteristics on high-resolution
CT. Acta Radiol 1999;40:496–504.
19. Erasmus JJ, Connolly JE, McAdams HP,
Roggli VL. Solitary pulmonary nodules. I.
Morphologic evaluation for differentiation of be-
nign andmalignant lesions. RadioGraphics 2000;
20:43–58.
20. Hasegawa M, Sone S, Takashima S, et al.
Growth rate of small lung cancers detected
on mass CT screening. Br J Radiol 2000;73:
1252–1259.
21. Hyodo T, Kanazawa S, Dendo S, et al. In-
trapulmonary lymph nodes: thin-section CT
findings, pathological findings, and CT differ-
ential diagnosis from pulmonary metastatic
nodules. Acta Med Okayama 2004;58:235–
240.
22. Oshiro Y, Kusumoto M, Moriyama N, et al.
Intrapulmonary lymph nodes: thin-section
CT features of 19 nodules. J Comput Assist
Tomogr 2002;26:553–557.
23. Swensen SJ, Jett JR, Sloan JA, et al. Screen-
ing for lung cancer with low-dose spiral com-
puted tomography. Am J Respir Crit Care
Med 2002;165:508–513.
24. Swensen SJ, Jett JR, Hartman TE, et al. CT
screening for lung cancer: 5-year prospec-
tive experience. Radiology 2005;235:259–
265.
25. Thunnissen FB, Schuurbiers OC, den Bakker
MA. A critical appraisal of prognostic and
predictive factors for common lung cancers.
Histopathology 2006;48:779–786.
26. Revel MP, Merlin A, Peyrard S, et al. Soft-
ware volumetric evaluation of doubling times
for differentiating benign versus malignant
pulmonary nodules. AJR Am J Roentgenol
2006;187:135–142.
THORACIC IMAGING:Predictive Nodule Characteristics at Follow-up Xu et al
272 Radiology: Volume 250: Number 1—January 2009
